Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure

被引:53
作者
Hageman, G
van der Hoek, J
van Hout, M
van der Laan, G
Steur, EJ
de Bruin, W
Herholz, K
机构
[1] Hosp Enschede, Med Spectrum Twente, Dept Neurol, NL-7500 KA Enschede, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dutch Ctr Occupat Dis, Coronel Inst, NL-1100 DD Amsterdam, Netherlands
[3] Hosp Enschede, Med Spectrum Twente, Dept Clin Psychol, NL-7500 KA Enschede, Netherlands
[4] Hosp Enschede, Med Spectrum Twente, Dept Nucl Med, NL-7500 KA Enschede, Netherlands
[5] Univ Hosp Cologne, Max Planck Inst, Lab PET, Dept Psychiat & Neurol, D-50924 Cologne, Germany
关键词
Parkinsonism; solvents; neurotoxicity; occupational disease; chronic toxic encephalopathy;
D O I
10.1007/s004150050334
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
It is well known that exposure to manganese, solvents, or carbon monoxide in an occupational setting may lead to central nervous system damage and parkinsonism. The most important solvents in this respect are methanol, toluene, carbon disulfide, and n-hexane, We describe three patients who had been exposed to various solvents for more than 20 years (25, 34, and 46 years). They presented with parkinsonism, pyramidal signs, mild cognitive decline, and unresponsiveness to levodopa, Two patients had a predominantly axonal and sensory polyneuropathy of the lower legs with fasciculations in one of them. Parkinsonian features were progressive, even after the patients had stopped work. We present clinical data, neuropsychological findings, and results of brain computed tomography or magnetic resonance imaging, electroneuromyography, evoked potentials, single photon emission computed tomography, and positron-emission tomography. There is growing evidence that various organic solvents give rise to a parkinsonism syndrome with pyramidal features in susceptible individuals.
引用
收藏
页码:198 / 206
页数:9
相关论文
共 44 条
[1]  
AASERUD O, 1990, AM J IND MED, V18, P25
[2]  
AGNEW J, 1994, OCCUPATION NEUROLOGY, P113
[3]  
ARLIENSOBORG P, 1992, SOLVENT NEUROTOXICIT, P199
[4]  
Brooks D. J., 1993, Neurology, V43, pS6
[5]   THE RELATIONSHIP BETWEEN LOCOMOTOR DISABILITY, AUTONOMIC DYSFUNCTION, AND THE INTEGRITY OF THE STRIATAL DOPAMINERGIC SYSTEM IN PATIENTS WITH MULTIPLE SYSTEM ATROPHY, PURE AUTONOMIC FAILURE, AND PARKINSONS-DISEASE, STUDIED WITH PET [J].
BROOKS, DJ ;
SALMON, EP ;
MATHIAS, CJ ;
QUINN, N ;
LEENDERS, KL ;
BANNISTER, R ;
MARSDEN, CD ;
FRACKOWIAK, RSJ .
BRAIN, 1990, 113 :1539-1552
[6]   DIFFERING PATTERNS OF STRIATAL F-18 DOPA UPTAKE IN PARKINSONS-DISEASE, MULTIPLE SYSTEM ATROPHY, AND PROGRESSIVE SUPRANUCLEAR PALSY [J].
BROOKS, DJ ;
IBANEZ, V ;
SAWLE, GV ;
QUINN, N ;
LEES, AJ ;
MATHIAS, CJ ;
BANNISTER, R ;
MARSDEN, CD ;
FRACKOWIAK, RSJ .
ANNALS OF NEUROLOGY, 1990, 28 (04) :547-555
[7]   STRIATAL D2 RECEPTOR STATUS IN PATIENTS WITH PARKINSONS-DISEASE, STRIATONIGRAL DEGENERATION, AND PROGRESSIVE SUPRANUCLEAR PALSY, MEASURED WITH C-11 RACLOPRIDE AND POSITRON EMISSION TOMOGRAPHY [J].
BROOKS, DJ ;
IBANEZ, V ;
SAWLE, GV ;
PLAYFORD, ED ;
QUINN, N ;
MATHIAS, CJ ;
LEES, AJ ;
MARSDEN, CD ;
BANNISTER, R ;
FRACKOWIAK, RSJ .
ANNALS OF NEUROLOGY, 1992, 31 (02) :184-192
[8]   POLYNEURITIS CRANIALIS ASSOCIATED WITH INDUSTRIAL TRICHLOROETHYLENE POISONING [J].
BUXTON, PH ;
HAYWARD, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1967, 30 (06) :511-+
[9]   The spectrum of neuroimaging abnormalities in solvent abuse and their clinical correlation [J].
Caldemeyer, KS ;
Armstrong, SW ;
George, KK ;
Moran, CC ;
Pascuzzi, RM .
JOURNAL OF NEUROIMAGING, 1996, 6 (03) :167-173
[10]  
CASSITO MG, 1994, HDB CLIN NEUROLOGY, V20, P39